BL
NMTC icon

Bleichroeder LP’s NeuroOne Medical Technologies NMTC Stock Holding History

Bleichroeder LP’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.11M Hold
666,667
– – 0.54% 25
2025
Q4 		$3.03M Hold
666,667
– – 0.53% 24
2025
Q3 		$3.55M Hold
666,667
– – 0.69% 20
2025
Q2 		$2.71M Buy
+666,667
New +$2.46M 0.67% 18
2022
Q1 		– Sell
-62,500
Closed -$728K – 115
2021
Q4 		$728K Buy
+62,500
New +$1.01M 0.11% 56

Other funds holding NMTC

BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bleichroeder LP's NMTC Position: Q1 2026 in Review

Bleichroeder LP held its NeuroOne Medical Technologies (NMTC) position steady in Q1 2026 at 666,667 shares worth $3.11M. The position accounts for 0.54% of the portfolio, ranked #25.

Bleichroeder LP first reported a position in NMTC in Q4 2021 and has held it in 5 quarters since. The position peaked at $3.55M in Q3 2025. 32 funds tracked by Wall St. Rank hold NMTC as of Q1 2026.

  • Bleichroeder LP held 666,667 shares of NeuroOne Medical Technologies worth $3.11M as of Q1 2026.
  • Bleichroeder LP left its NeuroOne Medical Technologies share count unchanged in Q1 2026.
  • NeuroOne Medical Technologies made up 0.54% of Bleichroeder LP's portfolio in Q1 2026, its #25 holding.
  • Bleichroeder LP first reported a position in NeuroOne Medical Technologies in Q4 2021 and has held it in 5 quarters since.
  • Bleichroeder LP's NeuroOne Medical Technologies position peaked at $3.55M in Q3 2025.
  • 32 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q1 2026.

Based on Bleichroeder LP's 13F filing for Q1 2026, filed 14 May 2026.